CAMPTOTHECIN

Synonyms. Camptothecin; Camptothecine; D-Camptothecin; (S)-Camptothecin; (+)-Camptothecin; (S)-(+)-Camptothecin; 20(S)-Camptothecine; 21,22-Secocamptothecin-21-oic acid lactone; (S)-4-Ethyl-4-hydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; (+)-Camptothecine;

CAMPTOTHECIN

 

PRODUCT IDENTIFICATION

CAS RN

7689-03-4

EINECS RN

 

FORMULA

C20H16N2O4

MOLE WEIGHT

348.36

H.S CODE

2939.99.0000

SMILES

c12c(c(n3Cc4c(c3c2)nc2ccccc2c4)=O)COC([C@@]1(CC)O)=O

CLASSIFICATION

Antineoplastic, Topoisomerase Inhibitor, Antitumor alkaloid

EXTRA NOTES

An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA Topoisomerases, Type I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity.

 

PHYSICAL AND CHEMICAL PROPERTIES

PHYSICAL STATE.

yellowish powder

MELTING POINT

260 C (Decomposes)

BOILING POINT

 

DENSITY

 

SOLUBILITY IN WATER

Insoluble

SOLVENT SOLUBILITY Soluble in methanol, ethanol, acetonirile

VAPOR DENSITY

 

log P(octanol-water)

 

VAPOR PRESSURE

 

AUTOIGNITION TEMP

 
pH

 

REFRACTIVE INDEX

 

FLASH POINT

 

 

STABILITY AND REACTIVITY
STABILITY Stable under normal conditions.

INCOMPATIBLE MATERIALS

Strong acids, Strong bases

POLYMERIZATION

Has not been reported

NFPA RATINGS

Health: 2,Flammability:0, Reactivity: 0

 

EXTERNAL LINKS & GENERAL DESCRIPTION

This quinoline based alkaloid was found in the bark of the Chinese camptotheca tree. Camptotheca goes by many names in China, including "happy tree", "dragon tree" and "fine tree".Chinese have used the "happy tree" in traditional medicine for thousands of years. It has been used for psoriasis, leukemia and diseases of liver, gallbladder, spleen, and stomach. During the last half century, scientists have discovered its potential as a selective anticancer drug. The unique mode of action for this potent cytotoxic compound was found to act via inhibition of an enzyme known as DNA topoisomerase I. (http://www.scripps.edu/)

Camptothecin is an anti-cancer monoterpene indole alkaloid. The gene encoding 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase (designated as CaHDR), the last catalytic enzyme of the MEP pathway for terpenoid biosynthesis, was isolated from camptothecin-producing Camptotheca acuminata. The full-length cDNA of CaHDR was 1686 bp encoding 459 amino acids. Comparison of the cDNA and genomic DNA of CaHDR revealed that there was no intron in genomic CaHDR. Southern blot analysis indicated that CaHDR belonged to a low-copy gene family. RT-PCR analysis revealed that CaHDR expressed constitutively in all tested plant organs with the highest expression level in flowers, and the expression of CaHDR could be induced by 100 ¥ìM methyl-jasmonate (MeJA), but not by 100 mg/L salicylic acid (SA) in the callus of C. acuminata. The complementation of CaHDR in Escherichia coli ispH mutant MG1655 demonstrated its function. [BMB reports 2008; 41(2): 112-118] (http://www.jbmb.or.kr/)

Camptothecin derivatives are clinically used antitumor alkaloids that belong to monoterpenoid indole alkaloids. In this study, we investigated the biosynthetic pathway of camptothecin from [1-13C]glucose (Glc) by in silico and in vivo studies. The in silico study measured the incorporation of Glc into alkaloids using the Atomic Reconstruction of Metabolism software and predicted the labeling patterns of successive metabolites from [1-13C]Glc. The in vivo study followed incorporation of [1-13C]Glc into camptothecin with hairy roots of Ophiorrhiza pumila by 13C nuclear magnetic resonance spectroscopy. The 13C-labeling pattern of camptothecin isolated from the hairy roots clearly showed that the monoterpene-secologanin moiety was synthesized via the 2C-methyl-D-erythritol 4-phosphate pathway, not via the mevalonate pathway. This conclusion was supported by differential inhibition of camptothecin accumulation by the pathway-specific inhibitors (fosmidomycin and lovastatin). The quinoline moiety from tryptophan was also labeled as predicted by the Atomic Reconstruction of Metabolism program via the shikimate pathway. These results indicate that camptothecin is formed by the combination of the 2C-methyl-D-erythritol 4-phosphate pathway and the shikimate pathway. This study provides the innovative example for how a computer-aided comprehensive metabolic analysis will refine the experimental design to obtain more precise biological information. (http://www.plantphysiol.org/)

 

Topoisomerase inhibitor is a substance that blocks topoisomerases (enzymes that break and rejoin DNA strands and are needed for cells to divide and grow). Blocking these enzymes may kill cancer cells. Certain topoisomerase inhibitors are being studied in the treatment of cancer.

Topoisomerase inhibitor

CAS RN.

Aclarubicin

57576-44-0

Amrubicin

110267-81-7
Amsacrine 51264-14-3
Belotecan Hydrochloride 213819-48-8

Belotecan

256411-32-2

Camptothecin

7689-03-4

Daunorubicin

20830-81-3
Daunorubicin hydrochloride 23541-50-6

Doxorubicin

23214-92-8
Doxorubicin hydrochloride 25316-40-9
Doxorubicin citrate 111266-55-8
Edotecarin 174402-32-5

Epirubicin

56420-45-2
Epirubicin hydrochloride 56390-09-1
Etoposide 33419-42-0
Etoposide phosphate 117091-64-2

Idarubicin

58957-92-9
Idarubicin 58957-92-9
Idronoxil 81267-65-4
Irinotecan hydrochloride 136572-09-3

Irinotecan

97682-44-5
Ledoxantrone trihydrochloride 119221-49-7
Lurtotecan dihydrochloride 155773-58-3
Mitoxantrone 65271-80-9
Mitoxantrone hydrochloride 70476-82-3

Pirarubicin

72496-41-4

Pixantrone

144510-96-3
Pixantrone maleate 144675-97-8
Rubitecan 91421-42-0
Temafloxacin hydrochloride 105784-61-0

Teniposide

29767-20-2

Topotecan 70476-82-3
Topotecan hydrochloride 119413-54-6

Valrubicin

56124-62-0

Zorubicin

54083-22-6

 

SALES SPECIFICATION

APPEARANCE

yellowish crystalline powder
ASSAY 95.0~103.0% (HPLC)

TOTAL ASH

0.3% max

SPECIFIC ROTATION +37.0° ~ +42.0 (c=0.4 chloroform:methanol= 8:2)

RELATED SUBSTANCES

2.0% max (total impurity)

MELTING POINT
259 ~ 263 C
PARTICLE SIZE

100 mesh

LOSS ON DRYING 3.0% max
MICROBIOLOGICAL TEST

Total plate count:1000cfu/g max
Yeast & mold:100 cfu/g max
E.coli:Negative
Salmonella:Negative

 

TRANSPORT & REGULATORY INFORMATION

UN NO.

1544

HAZARD CLASS

6.1
PACKING GROUP III

 

SAFETY INFORMATION

HAZARD OVERVIEW

Toxic if swallowed.

GHS

 

SIGNAL WORD

Danger

PICTOGRAMS

HAZARD STATEMENTS

H301

P STATEMENTS

P301 + P310

EC DIRECTIVES

 

HAZARD CODES

T

RISK PHRASES

25

SAFETY PHRASES

26-36/37/39-45

 

PACKING